User login

The Florida Society of Ophthalmology

The EyeMDs


News from the FSO

From the American Academy of Ophthalmology

Monday, July 30, 2012 - 10:45

Florida Society of Ophthalmology’s Proposals Receive Approval Regarding Inclusion and Scope of Practice Expansion
 

Tuesday, July 31, 2012 - 10:45

From the American Academy of Ophthalmology

Friday, August 3, 2012 - 10:45

From the American Academy of Ophthalmology

Thursday, August 9, 2012 - 10:30

From the American Academy of Ophthalmology

Tuesday, August 14, 2012 - 10:30

From the American Academy of Ophthalmology

Friday, August 17, 2012 - 10:30

From the American Academy of Ophthalmology

The U.S. Food and Drug Administration has approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. The drug’s safety and effectiveness to treat DME were established in two clinical studies that showed a 34 to 45 percent improvement in patients treated monthly with 0.3 mg of Lucentis over a two-year period. Ophthalmologists should check with their Medicare carriers to determine coverage for Lucentis to treat DME.

Friday, August 17, 2012 - 10:30

From the American Academy of Ophthalmology

 

Tuesday, August 28, 2012 - 10:15

From the American Academy of Ophthalmology

Tuesday, August 28, 2012 - 10:15

From the American Academy of Ophthalmology

Friday, August 31, 2012 - 17:00

Pages

FSO

About

 
 
 
 
 
 

Why Join?

 
 
 
 
 
 
 
 

Join

 
 
 
 

Contribute

Pay Dues

Upcoming Events

Thursday, January 23, 2020
Ruth's Chris
West Palm Beach, FL
Tuesday, January 28, 2020
Florida State Capitol
Tallahassee, FL
Wednesday, April 22, 2020 to Saturday, April 25, 2020
Renaissance Downtown
Washington, DC
Friday, June 12, 2020
The Ritz-Carlton Orlando, Grande Lakes
Orlando, FL